(MYOK) |
| 0 (0%) 08-01 20:09 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 1.22 |
| Resistance 1: | 1.09 |
| Pivot price: | 1.01 |
| Support 1: | 0.88 |
| Support 2: | 0.73 |
| 52w High: | |
| 52w Low: |
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Thu, 20 Nov 2025
Kia showcases new EV4 at contemporary Korean bathhouse in Dezeen video - Dezeen
Mon, 05 Feb 2024
Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases - Frontiers
Tue, 27 Jun 2023
11 best new Instagram bakeries in Hong Kong for cakes, pastries and more - South China Morning Post
Mon, 05 Oct 2020
Bristol-Myers’ $13 Billion Deal for MyoKardia Spotlights Cardiac Drugs - Barron's
Mon, 05 Oct 2020
MyoKardia soars 59% after Bristol-Myers agrees to acquire it for $13 billion in cash - markets.businessinsider.com
Fri, 19 Jul 2019
MyoKardia reclaims US royalty rights to heart drugs, completing conscious uncoupling from Sanofi - Endpoints News
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |